The administration of metformin, an insulin sensitiser, in the treatment of non-pregnant PCOS women is well established.19 Evidence shows its usefulness in reducing late miscarriages and preterm deliveries; however, its efficacy on other complications is debated and the mechanism of action is not fully understood.20–23. This evidence concerns the gene INS and polycystic ovary syndrome.